A detailed history of Wealth Alliance Advisory Group, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Wealth Alliance Advisory Group, LLC holds 7,332 shares of ABBV stock, worth $1.42 Million. This represents 0.31% of its overall portfolio holdings.

Number of Shares
7,332
Previous 7,702 4.8%
Holding current value
$1.42 Million
Previous $1.4 Million 10.34%
% of portfolio
0.31%
Previous 0.35%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 30, 2024

SELL
$154.79 - $180.76 $57,272 - $66,881
-370 Reduced 4.8%
7,332 $1.26 Million
Q1 2024

Apr 15, 2024

SELL
$159.82 - $182.1 $33,082 - $37,694
-207 Reduced 2.62%
7,702 $1.4 Million
Q4 2023

Jan 10, 2024

BUY
$137.6 - $154.97 $825 - $929
6 Added 0.08%
7,909 $1.23 Million
Q3 2023

Oct 10, 2023

SELL
$133.59 - $154.65 $539,570 - $624,631
-4,039 Reduced 33.82%
7,903 $1.18 Million
Q2 2023

Jul 13, 2023

SELL
$132.51 - $164.9 $49,823 - $62,002
-376 Reduced 3.05%
11,942 $1.61 Million
Q1 2023

May 02, 2023

BUY
$144.61 - $166.54 $367,020 - $422,678
2,538 Added 25.95%
12,318 $1.96 Million
Q4 2022

Jan 17, 2023

BUY
$138.31 - $165.87 $30,981 - $37,154
224 Added 2.34%
9,780 $0
Q3 2022

Oct 12, 2022

BUY
$134.21 - $153.93 $319,688 - $366,661
2,382 Added 33.2%
9,556 $1.28 Million
Q2 2022

Jul 08, 2022

BUY
$137.62 - $174.96 $73,213 - $93,078
532 Added 8.01%
7,174 $1.1 Million
Q1 2022

Apr 18, 2022

BUY
$131.98 - $163.75 $223,442 - $277,228
1,693 Added 34.21%
6,642 $1.08 Million
Q4 2021

Jan 13, 2022

BUY
$107.43 - $135.93 $29,220 - $36,972
272 Added 5.82%
4,949 $670,000
Q3 2021

Oct 08, 2021

BUY
$106.4 - $120.78 $59,903 - $67,999
563 Added 13.68%
4,677 $505,000
Q1 2021

Apr 28, 2021

SELL
$102.3 - $112.62 $30,690 - $33,786
-300 Reduced 6.8%
4,114 $445,000
Q3 2020

Oct 08, 2020

SELL
$85.91 - $100.83 $27,319 - $32,063
-318 Reduced 6.72%
4,414 $387,000
Q2 2020

Jul 08, 2020

BUY
$73.37 - $98.18 $12,766 - $17,083
174 Added 3.82%
4,732 $465,000
Q1 2020

Apr 15, 2020

BUY
$64.5 - $97.79 $41,022 - $62,194
636 Added 16.22%
4,558 $347,000
Q4 2019

Jan 24, 2020

BUY
$72.13 - $90.25 $1,298 - $1,624
18 Added 0.46%
3,922 $347,000
Q3 2019

Nov 01, 2019

SELL
$62.98 - $75.72 $7,683 - $9,237
-122 Reduced 3.03%
3,904 $287,000
Q2 2019

Jul 17, 2019

BUY
$65.7 - $83.98 $6,570 - $8,398
100 Added 2.55%
4,026 $283,000
Q1 2019

May 14, 2019

BUY
$77.14 - $90.79 $10,105 - $11,893
131 Added 3.45%
3,926 $306,000
Q4 2018

Jan 28, 2019

BUY
$77.85 - $96.01 $78,862 - $97,258
1,013 Added 36.41%
3,795 $350,000
Q3 2018

Oct 19, 2018

BUY
$88.91 - $98.84 $88 - $98
1 Added 0.04%
2,782 $263,000
Q2 2018

Jul 20, 2018

SELL
$89.78 - $106.23 $89 - $106
-1 Reduced 0.04%
2,781 $258,000
Q1 2018

Jun 01, 2018

BUY
$92.01 - $123.21 $255,971 - $342,770
2,782 New
2,782 $263,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $342B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Wealth Alliance Advisory Group, LLC Portfolio

Follow Wealth Alliance Advisory Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wealth Alliance Advisory Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wealth Alliance Advisory Group, LLC with notifications on news.